All News

Due to physician shortages, pharmacists represent a new avenue to increase accessibility to antivirals.

Announced by both companies today, the new combined company will consist of franchises across immunology, hematologic oncology, medical aesthetics, neuroscience, women’s health, eye care, and virology.

An independent review of pharmacy benefit managers (PBMs) in Ohio indicates that PBM pricing practices likely contribute to rising health care costs.

The approved product is therapeutically equivalent to Genentech’s Tamiflu I Capsules, 30 mg, 45 mg, and 75 mg.

A phase 2a study is evaluating cerdulatinib, an oral SYK/JAK inhibitor, in pre-treated patients with relapsed/refractory follicular lymphoma.

Top news of the day from across the health care landscape.

The new syringe is designed to improve the subcutaneous administration of lanreotide (Somatuline Depot, Ipsen Biopharmaceuticals).

Based on this analysis, a standardized TOC pharmacy education program for COPD was implemented at Rhode Island Hospital in late 2018.

The supplemental New Drug Application supports the expansion of niraparib’s indication as a late-line therapeutic option for patients with ovarian cancer.

In an effort to combat the opioid epidemic, Walgreens has introduced its recently announced an addition to its drug disposal program in the form of DisposeRx packets.

Why did the doctor lower this patient's gabapentin dose?

Rotavirus is a contagious viral infection causing gastroenteritis that generally affects infants and young children.

Receptor-modified T cells successfully controlled chronic hepatitis B virus, showing promise as a potential cure for the disease.

Top news of the day from across the health care landscape.

The effectiveness and safety of bremelanotide were studied in a pair of 24-week, randomized, double-blind, placebo-controlled trials in 1247 premenopausal women with acquired, generalized HSDD.

This approval expands tezacaftor/ivacaftor’s indication to include patients ages 6 and older with cystic fibrosis who have certain genetic mutations.

This approval expands tezacaftor/ivacaftor’s indication to include patients ages 6 and older with cystic fibrosis who have certain genetic mutations.

Introduced by U.S. Senator Kamala D. Harris (D-CA), the bill requires all insurance plans to cover HIV prevention medications and services without out-of-pocket costs. The bill also facilitates access to PrEP for uninsured individuals.

Parabens are commonly used as preservatives in cosmetics, dermatological topical preparations, oral and parenteral medications, and in food products.

Patients with multiple sclerosis who switched disease-modifying treatments at least twice had a higher relative risk of developing cancer.

Bausch + Lomb has announced the US launch of their ULTRA Multifocal for Astigmatism contact lenses, the only multifocal toric lens available as a standard offering in the company’s fit set.

Officials with the FDA have approved Allergan’s supplemental biologics application (sBLA) for onabotulinumtoxinA (Botox) for the treatment of children, ages 2 to 17 years, with upper limb spasticity.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

The goal, according to agency officials, is to ensure product approval and removal decisions are science-based and that the agency’s benefit-risk framework considers not only the outcomes of prescription opioids when used as prescribed, but also the public health effects of inappropriate use.

According to the CDC, approximately 1 of 3 patients with type 1 and 2 diabetes mellitus (DM) has CKD. What do we need to know about patients with DM and CKD?

2019 Pharmacy Quality Alliance Annual Meeting included discussions on measures to improve medication services and how pharmacists can play a larger role in the multidisciplinary care team.

Top news of the day from across the health care landscape.